{"gene":"ADD2","run_date":"2026-06-09T22:02:41","timeline":{"discoveries":[{"year":1999,"finding":"Beta-adducin (ADD2) is required for RBC membrane stability in vivo; its absence causes osmotic fragility, spherocytosis, and dehydration. Loss of beta-adducin reduces alpha-adducin incorporation into the RBC membrane skeleton to ~30% of normal and triggers a 5-fold compensatory increase in gamma-adducin incorporation into the membrane skeleton.","method":"Gene targeting / knockout mouse (exons 9-13 deleted); membrane fractionation and protein quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, quantitative membrane fractionation, replicated across multiple assays in a single rigorous study","pmids":["10485892"],"is_preprint":false},{"year":2009,"finding":"Beta-adducin (ADD2) is required for hippocampal long-term potentiation (LTP) and long-term depression (LTD); its loss impairs synaptic plasticity, motor coordination and learning. Beta-adducin KO also reduces phosphorylation of adducin and alpha-adducin expression levels while upregulating gamma-adducin in hippocampus, cerebellum, and neocortex, indicating coordinated regulation of adducin subunits. Additionally, Add2 mRNA localizes to dendrites.","method":"Beta-adducin knockout mice; electrophysiology (LTP/LTD recordings); Western blot for phosphorylation and expression; in situ hybridization for mRNA localization","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined electrophysiological and behavioral phenotypes, multiple orthogonal methods, single lab","pmids":["19900187"],"is_preprint":false},{"year":2014,"finding":"TDP-43 stabilizes Add2 mRNA post-transcriptionally; depletion of TDP-43 in HeLa and HEK293 cells decreases Add2 transcript levels by reducing mRNA stability rather than by modulating 3' end processing or polyadenylation. The effect is not mediated through the downstream element (DSE) of the Add2 polyadenylation site, and TDP-43 does not interact with polyadenylation factors CstF-64 or CPSF160.","method":"Chimeric minigene transfection; siRNA-mediated TDP-43 knockdown; mRNA stability assay; in vitro RNA binding; Co-IP for CstF-64 and CPSF160","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (minigene, KD, stability assay, binding assays) in a single study, single lab","pmids":["25602706"],"is_preprint":false},{"year":2013,"finding":"The distal brain-specific polyadenylation site (PAS4) of Add2 pre-mRNA requires both a hexanucleotide motif and a downstream sequence element (DSE) containing UG repeats for efficient 3' end processing; deletion or point mutation of these elements reduces mature mRNA and activates cryptic polyadenylation sites. RNA-protein complexes form at the DSE, and pull-down identified PTB, TDP-43, FBP1, FBP2, nucleolin, RNA helicase A, and vigilin as DSE-binding proteins.","method":"Chimeric minigene transfection with deletion/point-mutation analysis; RNA-EMSA; RNA pull-down/mass spectrometry","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of cis-elements combined with RNA-protein interaction assays, single lab, multiple orthogonal methods","pmids":["23554949"],"is_preprint":false},{"year":2013,"finding":"Long-distance upstream cis-acting elements (located >4.5–5 kb upstream of PAS4) regulate Add2 pre-mRNA 3' end processing at the distal brain-specific polyadenylation site: one 257-nt element is essential for PAS4 activity, while a second element ~4.5 kb upstream suppresses PAS4 processing.","method":"In vivo minigene transfection with deletion analysis; polyadenylation site usage assay","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — minigene functional assays with multiple deletion constructs, single lab, novel finding replicated across constructs","pmids":["23411391"],"is_preprint":false},{"year":2005,"finding":"ADD2 expression is induced ~100-fold during erythropoietic differentiation of CD34+ stem cells; 5'RACE identified a novel erythroid-specific starting exon and putative promoter for ADD2 distinct from the constitutive promoter.","method":"Real-time RT-PCR on sorted primary erythroid precursors; 5'RACE analysis","journal":"Experimental hematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative expression profiling plus 5'RACE structural identification of a novel promoter, single lab","pmids":["15963851"],"is_preprint":false},{"year":2019,"finding":"miR-218 directly targets ADD2 mRNA and negatively regulates ADD2 protein expression; miR-218 overexpression suppresses migration and invasion of endometrial cancer cells, and this effect is rescued by ADD2 re-expression, placing ADD2 downstream of miR-218 in a pro-metastatic pathway.","method":"Luciferase reporter gene assay (3'UTR targeting); Western blot; wound healing and Matrigel invasion assays; rescue experiments","journal":"European review for medical and pharmacological sciences","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — luciferase reporter confirms direct miRNA targeting, rescue experiment links ADD2 to phenotype, single lab with multiple assays","pmids":["30840261"],"is_preprint":false}],"current_model":"ADD2 (beta-adducin) is a cytoskeletal protein that stabilizes the red blood cell membrane by promoting alpha-adducin incorporation into the spectrin-actin skeleton, regulates synaptic actin dynamics at dendritic spines to support hippocampal LTP/LTD and motor learning, has its expression controlled by a novel erythroid-specific promoter and by TDP-43-mediated mRNA stabilization, undergoes tissue-specific alternative polyadenylation governed by both proximal cis-elements and long-distance upstream regulatory sequences, and is directly repressed post-transcriptionally by miR-218 in a pathway that controls cancer cell invasiveness."},"narrative":{"mechanistic_narrative":"ADD2 (beta-adducin) is a membrane-skeletal cytoskeletal protein that maintains red blood cell membrane integrity and supports synaptic actin remodeling in the nervous system [PMID:10485892, PMID:19900187]. In erythrocytes, beta-adducin is required for membrane stability in vivo: its loss causes osmotic fragility, spherocytosis, and dehydration, reduces incorporation of alpha-adducin into the spectrin-actin skeleton to ~30% of normal, and triggers a compensatory increase in gamma-adducin, indicating that adducin subunits are coordinately balanced within the membrane skeleton [PMID:10485892]. The same subunit interdependence and coordinated regulation operate in the brain, where beta-adducin is required for hippocampal LTP and LTD and for motor coordination and learning, and where its loss reduces adducin phosphorylation and alpha-adducin levels while upregulating gamma-adducin [PMID:19900187]. ADD2 expression and transcript fate are heavily regulated at multiple post-transcriptional levels: a novel erythroid-specific promoter drives ~100-fold induction during erythroid differentiation [PMID:15963851]; tissue-specific 3' end processing at a distal brain-specific polyadenylation site (PAS4) depends on a hexanucleotide motif plus a UG-rich downstream element and on long-distance upstream cis-elements that variously activate or suppress PAS4 usage [PMID:23554949, PMID:23411391]; TDP-43 stabilizes Add2 mRNA post-transcriptionally rather than altering polyadenylation [PMID:25602706]; and miR-218 directly represses ADD2 to control cancer cell migration and invasion [PMID:30840261].","teleology":[{"year":1999,"claim":"Established that beta-adducin has a non-redundant role in red cell membrane architecture, answering whether the beta subunit is structurally required and how the skeleton compensates for its loss.","evidence":"Gene-targeted knockout mouse with membrane fractionation and quantitative protein analysis of adducin subunits","pmids":["10485892"],"confidence":"High","gaps":["Does not define the molecular interface between beta-adducin and alpha-adducin or spectrin-actin","Mechanism of compensatory gamma-adducin upregulation not resolved","No structural model of the adducin heterocomplex"]},{"year":2005,"claim":"Identified a dedicated erythroid-specific promoter and starting exon, explaining how ADD2 expression is massively upregulated during red cell production.","evidence":"Real-time RT-PCR on sorted primary erythroid precursors plus 5'RACE in CD34+ cells","pmids":["15963851"],"confidence":"Medium","gaps":["Transcription factors driving the erythroid promoter not identified","Functional consequence of the alternative starting exon on protein product unknown"]},{"year":2009,"claim":"Extended beta-adducin function beyond erythrocytes to the nervous system, showing it is required for synaptic plasticity and learning and that adducin subunits are coordinately regulated in neural tissue.","evidence":"Knockout mice with LTP/LTD electrophysiology, behavioral testing, Western blot, and in situ hybridization for dendritic mRNA localization","pmids":["19900187"],"confidence":"Medium","gaps":["Molecular link between adducin and synaptic actin dynamics at spines not mechanistically defined","Kinase responsible for adducin phosphorylation in neurons not identified","How dendritic Add2 mRNA localization couples to local translation unresolved"]},{"year":2013,"claim":"Defined the cis-regulatory logic of tissue-specific 3' end processing, showing both proximal and long-distance elements govern usage of the brain-specific distal polyadenylation site PAS4.","evidence":"Chimeric minigene transfection with deletion/point mutagenesis, RNA-EMSA, and RNA pull-down/mass spectrometry identifying DSE-binding proteins","pmids":["23554949","23411391"],"confidence":"Medium","gaps":["Functional roles of individual DSE-binding proteins (PTB, FBP1/2, nucleolin, RNA helicase A, vigilin) not dissected","Mechanism by which a >4.5 kb upstream element suppresses PAS4 processing unknown","Endogenous (non-minigene) confirmation of long-distance element function not established"]},{"year":2014,"claim":"Distinguished mRNA stabilization from 3' end processing as the mechanism by which TDP-43 controls Add2 transcript abundance.","evidence":"Chimeric minigene, siRNA knockdown, mRNA stability assay, in vitro RNA binding, and Co-IP against polyadenylation factors in HeLa/HEK293","pmids":["25602706"],"confidence":"Medium","gaps":["Binding site of TDP-43 within Add2 mRNA not mapped","Physiological context (erythroid vs neuronal) of TDP-43 regulation not addressed","Effectors mediating stabilization downstream of TDP-43 unknown"]},{"year":2019,"claim":"Placed ADD2 downstream of a miRNA in a cancer context, showing direct post-transcriptional repression by miR-218 controls tumor cell invasiveness.","evidence":"3'UTR luciferase reporter assay, Western blot, wound-healing and Matrigel invasion assays, and ADD2 re-expression rescue in endometrial cancer cells","pmids":["30840261"],"confidence":"Medium","gaps":["Mechanism by which ADD2 promotes migration/invasion not defined","Single cancer cell context without in vivo validation","Relationship to ADD2's cytoskeletal function in this setting unclear"]},{"year":null,"claim":"How ADD2's structural cytoskeletal role, its multilayered post-transcriptional regulation, and its context-specific functions in erythrocytes, neurons, and cancer are mechanistically integrated remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the adducin subunit complex from the corpus","Direct molecular partners at the spectrin-actin junction not biochemically mapped in the timeline","Causal mutation linking ADD2 to a human Mendelian disease not present"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,1]}],"pathway":[],"complexes":["spectrin-actin membrane skeleton"],"partners":["ADD1","ADD3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35612","full_name":"Beta-adducin","aliases":["Erythrocyte adducin subunit beta"],"length_aa":726,"mass_kda":80.9,"function":"Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to the erythrocyte membrane receptor SLC2A1/GLUT1 and may therefore provide a link between the spectrin cytoskeleton to the plasma membrane. Binds to calmodulin. Calmodulin binds preferentially to the beta subunit","subcellular_location":"Cytoplasm, cytoskeleton; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P35612/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADD2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ADD2","total_profiled":1310},"omim":[{"mim_id":"601568","title":"ADDUCIN 3; ADD3","url":"https://www.omim.org/entry/601568"},{"mim_id":"179490","title":"RAS-ASSOCIATED PROTEIN RAB3A; RAB3A","url":"https://www.omim.org/entry/179490"},{"mim_id":"125305","title":"ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49","url":"https://www.omim.org/entry/125305"},{"mim_id":"102681","title":"ADDUCIN 2; ADD2","url":"https://www.omim.org/entry/102681"},{"mim_id":"102680","title":"ADDUCIN 1; ADD1","url":"https://www.omim.org/entry/102680"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":62.7},{"tissue":"brain","ntpm":36.1}],"url":"https://www.proteinatlas.org/search/ADD2"},"hgnc":{"alias_symbol":["ADDB"],"prev_symbol":[]},"alphafold":{"accession":"P35612","domains":[{"cath_id":"-","chopping":"30-96","consensus_level":"medium","plddt":77.164,"start":30,"end":96},{"cath_id":"3.40.225.10","chopping":"121-324","consensus_level":"high","plddt":91.5759,"start":121,"end":324}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35612","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35612-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35612-F1-predicted_aligned_error_v6.png","plddt_mean":65.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADD2","jax_strain_url":"https://www.jax.org/strain/search?query=ADD2"},"sequence":{"accession":"P35612","fasta_url":"https://rest.uniprot.org/uniprotkb/P35612.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35612/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35612"}},"corpus_meta":[{"pmid":"10485892","id":"PMC_10485892","title":"Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10485892","citation_count":99,"is_preprint":false},{"pmid":"19900187","id":"PMC_19900187","title":"beta-adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the alpha- and gamma-adducin subunits.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19900187","citation_count":46,"is_preprint":false},{"pmid":"25602706","id":"PMC_25602706","title":"TDP-43 regulates β-adducin (Add2) transcript stability.","date":"2014","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/25602706","citation_count":42,"is_preprint":false},{"pmid":"15099822","id":"PMC_15099822","title":"Genotoxicity of 2-[2-(acetylamino)-4-[bis(2-hydroxyethyl)amino]-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole (PBTA-6) and 4-amino-3,3'-dichloro-5,4'-dinitro-biphenyl (ADDB) in goldfish (Carassius auratus) using the micronucleus test and the comet assay.","date":"2004","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/15099822","citation_count":30,"is_preprint":false},{"pmid":"9244430","id":"PMC_9244430","title":"Organization of the human beta-adducin gene (ADD2).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9244430","citation_count":23,"is_preprint":false},{"pmid":"8752329","id":"PMC_8752329","title":"Effects of lysine-to-glycine mutations in the ATP-binding consensus sequences in the AddA and AddB subunits on the Bacillus subtilis AddAB enzyme activities.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8752329","citation_count":19,"is_preprint":false},{"pmid":"12951058","id":"PMC_12951058","title":"Expression analysis of the human adducin gene family and evidence of ADD2 beta4 multiple splicing variants.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12951058","citation_count":18,"is_preprint":false},{"pmid":"30840261","id":"PMC_30840261","title":"MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30840261","citation_count":12,"is_preprint":false},{"pmid":"15963851","id":"PMC_15963851","title":"Expression of adducin genes during erythropoiesis: a novel erythroid promoter for ADD2.","date":"2005","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/15963851","citation_count":8,"is_preprint":false},{"pmid":"23554949","id":"PMC_23554949","title":"Characterization of the distal polyadenylation site of the ß-adducin (Add2) pre-mRNA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23554949","citation_count":8,"is_preprint":false},{"pmid":"25785112","id":"PMC_25785112","title":"Common variant rs7597774 in ADD2 is associated with dilated cardiomyopathy in Chinese Han population.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25785112","citation_count":7,"is_preprint":false},{"pmid":"17499012","id":"PMC_17499012","title":"Quantification of a potent mutagenic 4-amino-3,3'-dichloro-5,4'-dinitrobiphenyl (ADDB) and the related chemicals in water from the Waka River in Wakayama, Japan.","date":"2007","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/17499012","citation_count":4,"is_preprint":false},{"pmid":"23411391","id":"PMC_23411391","title":"Long-distance regulation of Add2 pre-mRNA3'end processing.","date":"2013","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/23411391","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.27.650825","title":"Sludge liquefaction and stratification enable ultra-high digestion rate and resource recovery for waste activated sludge treatment","date":"2025-04-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.27.650825","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9183,"output_tokens":1889,"usd":0.027942,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8811,"output_tokens":2645,"usd":0.05509,"stage2_stop_reason":"end_turn"},"total_usd":0.083032,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Beta-adducin (ADD2) is required for RBC membrane stability in vivo; its absence causes osmotic fragility, spherocytosis, and dehydration. Loss of beta-adducin reduces alpha-adducin incorporation into the RBC membrane skeleton to ~30% of normal and triggers a 5-fold compensatory increase in gamma-adducin incorporation into the membrane skeleton.\",\n      \"method\": \"Gene targeting / knockout mouse (exons 9-13 deleted); membrane fractionation and protein quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, quantitative membrane fractionation, replicated across multiple assays in a single rigorous study\",\n      \"pmids\": [\"10485892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Beta-adducin (ADD2) is required for hippocampal long-term potentiation (LTP) and long-term depression (LTD); its loss impairs synaptic plasticity, motor coordination and learning. Beta-adducin KO also reduces phosphorylation of adducin and alpha-adducin expression levels while upregulating gamma-adducin in hippocampus, cerebellum, and neocortex, indicating coordinated regulation of adducin subunits. Additionally, Add2 mRNA localizes to dendrites.\",\n      \"method\": \"Beta-adducin knockout mice; electrophysiology (LTP/LTD recordings); Western blot for phosphorylation and expression; in situ hybridization for mRNA localization\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined electrophysiological and behavioral phenotypes, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"19900187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TDP-43 stabilizes Add2 mRNA post-transcriptionally; depletion of TDP-43 in HeLa and HEK293 cells decreases Add2 transcript levels by reducing mRNA stability rather than by modulating 3' end processing or polyadenylation. The effect is not mediated through the downstream element (DSE) of the Add2 polyadenylation site, and TDP-43 does not interact with polyadenylation factors CstF-64 or CPSF160.\",\n      \"method\": \"Chimeric minigene transfection; siRNA-mediated TDP-43 knockdown; mRNA stability assay; in vitro RNA binding; Co-IP for CstF-64 and CPSF160\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (minigene, KD, stability assay, binding assays) in a single study, single lab\",\n      \"pmids\": [\"25602706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The distal brain-specific polyadenylation site (PAS4) of Add2 pre-mRNA requires both a hexanucleotide motif and a downstream sequence element (DSE) containing UG repeats for efficient 3' end processing; deletion or point mutation of these elements reduces mature mRNA and activates cryptic polyadenylation sites. RNA-protein complexes form at the DSE, and pull-down identified PTB, TDP-43, FBP1, FBP2, nucleolin, RNA helicase A, and vigilin as DSE-binding proteins.\",\n      \"method\": \"Chimeric minigene transfection with deletion/point-mutation analysis; RNA-EMSA; RNA pull-down/mass spectrometry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of cis-elements combined with RNA-protein interaction assays, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23554949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Long-distance upstream cis-acting elements (located >4.5–5 kb upstream of PAS4) regulate Add2 pre-mRNA 3' end processing at the distal brain-specific polyadenylation site: one 257-nt element is essential for PAS4 activity, while a second element ~4.5 kb upstream suppresses PAS4 processing.\",\n      \"method\": \"In vivo minigene transfection with deletion analysis; polyadenylation site usage assay\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — minigene functional assays with multiple deletion constructs, single lab, novel finding replicated across constructs\",\n      \"pmids\": [\"23411391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ADD2 expression is induced ~100-fold during erythropoietic differentiation of CD34+ stem cells; 5'RACE identified a novel erythroid-specific starting exon and putative promoter for ADD2 distinct from the constitutive promoter.\",\n      \"method\": \"Real-time RT-PCR on sorted primary erythroid precursors; 5'RACE analysis\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative expression profiling plus 5'RACE structural identification of a novel promoter, single lab\",\n      \"pmids\": [\"15963851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-218 directly targets ADD2 mRNA and negatively regulates ADD2 protein expression; miR-218 overexpression suppresses migration and invasion of endometrial cancer cells, and this effect is rescued by ADD2 re-expression, placing ADD2 downstream of miR-218 in a pro-metastatic pathway.\",\n      \"method\": \"Luciferase reporter gene assay (3'UTR targeting); Western blot; wound healing and Matrigel invasion assays; rescue experiments\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — luciferase reporter confirms direct miRNA targeting, rescue experiment links ADD2 to phenotype, single lab with multiple assays\",\n      \"pmids\": [\"30840261\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADD2 (beta-adducin) is a cytoskeletal protein that stabilizes the red blood cell membrane by promoting alpha-adducin incorporation into the spectrin-actin skeleton, regulates synaptic actin dynamics at dendritic spines to support hippocampal LTP/LTD and motor learning, has its expression controlled by a novel erythroid-specific promoter and by TDP-43-mediated mRNA stabilization, undergoes tissue-specific alternative polyadenylation governed by both proximal cis-elements and long-distance upstream regulatory sequences, and is directly repressed post-transcriptionally by miR-218 in a pathway that controls cancer cell invasiveness.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ADD2 (beta-adducin) is a membrane-skeletal cytoskeletal protein that maintains red blood cell membrane integrity and supports synaptic actin remodeling in the nervous system [#0, #1]. In erythrocytes, beta-adducin is required for membrane stability in vivo: its loss causes osmotic fragility, spherocytosis, and dehydration, reduces incorporation of alpha-adducin into the spectrin-actin skeleton to ~30% of normal, and triggers a compensatory increase in gamma-adducin, indicating that adducin subunits are coordinately balanced within the membrane skeleton [#0]. The same subunit interdependence and coordinated regulation operate in the brain, where beta-adducin is required for hippocampal LTP and LTD and for motor coordination and learning, and where its loss reduces adducin phosphorylation and alpha-adducin levels while upregulating gamma-adducin [#1]. ADD2 expression and transcript fate are heavily regulated at multiple post-transcriptional levels: a novel erythroid-specific promoter drives ~100-fold induction during erythroid differentiation [#5]; tissue-specific 3' end processing at a distal brain-specific polyadenylation site (PAS4) depends on a hexanucleotide motif plus a UG-rich downstream element and on long-distance upstream cis-elements that variously activate or suppress PAS4 usage [#3, #4]; TDP-43 stabilizes Add2 mRNA post-transcriptionally rather than altering polyadenylation [#2]; and miR-218 directly represses ADD2 to control cancer cell migration and invasion [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that beta-adducin has a non-redundant role in red cell membrane architecture, answering whether the beta subunit is structurally required and how the skeleton compensates for its loss.\",\n      \"evidence\": \"Gene-targeted knockout mouse with membrane fractionation and quantitative protein analysis of adducin subunits\",\n      \"pmids\": [\"10485892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Does not define the molecular interface between beta-adducin and alpha-adducin or spectrin-actin\",\n        \"Mechanism of compensatory gamma-adducin upregulation not resolved\",\n        \"No structural model of the adducin heterocomplex\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified a dedicated erythroid-specific promoter and starting exon, explaining how ADD2 expression is massively upregulated during red cell production.\",\n      \"evidence\": \"Real-time RT-PCR on sorted primary erythroid precursors plus 5'RACE in CD34+ cells\",\n      \"pmids\": [\"15963851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Transcription factors driving the erythroid promoter not identified\",\n        \"Functional consequence of the alternative starting exon on protein product unknown\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended beta-adducin function beyond erythrocytes to the nervous system, showing it is required for synaptic plasticity and learning and that adducin subunits are coordinately regulated in neural tissue.\",\n      \"evidence\": \"Knockout mice with LTP/LTD electrophysiology, behavioral testing, Western blot, and in situ hybridization for dendritic mRNA localization\",\n      \"pmids\": [\"19900187\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular link between adducin and synaptic actin dynamics at spines not mechanistically defined\",\n        \"Kinase responsible for adducin phosphorylation in neurons not identified\",\n        \"How dendritic Add2 mRNA localization couples to local translation unresolved\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the cis-regulatory logic of tissue-specific 3' end processing, showing both proximal and long-distance elements govern usage of the brain-specific distal polyadenylation site PAS4.\",\n      \"evidence\": \"Chimeric minigene transfection with deletion/point mutagenesis, RNA-EMSA, and RNA pull-down/mass spectrometry identifying DSE-binding proteins\",\n      \"pmids\": [\"23554949\", \"23411391\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional roles of individual DSE-binding proteins (PTB, FBP1/2, nucleolin, RNA helicase A, vigilin) not dissected\",\n        \"Mechanism by which a >4.5 kb upstream element suppresses PAS4 processing unknown\",\n        \"Endogenous (non-minigene) confirmation of long-distance element function not established\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Distinguished mRNA stabilization from 3' end processing as the mechanism by which TDP-43 controls Add2 transcript abundance.\",\n      \"evidence\": \"Chimeric minigene, siRNA knockdown, mRNA stability assay, in vitro RNA binding, and Co-IP against polyadenylation factors in HeLa/HEK293\",\n      \"pmids\": [\"25602706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Binding site of TDP-43 within Add2 mRNA not mapped\",\n        \"Physiological context (erythroid vs neuronal) of TDP-43 regulation not addressed\",\n        \"Effectors mediating stabilization downstream of TDP-43 unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed ADD2 downstream of a miRNA in a cancer context, showing direct post-transcriptional repression by miR-218 controls tumor cell invasiveness.\",\n      \"evidence\": \"3'UTR luciferase reporter assay, Western blot, wound-healing and Matrigel invasion assays, and ADD2 re-expression rescue in endometrial cancer cells\",\n      \"pmids\": [\"30840261\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which ADD2 promotes migration/invasion not defined\",\n        \"Single cancer cell context without in vivo validation\",\n        \"Relationship to ADD2's cytoskeletal function in this setting unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ADD2's structural cytoskeletal role, its multilayered post-transcriptional regulation, and its context-specific functions in erythrocytes, neurons, and cancer are mechanistically integrated remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of the adducin subunit complex from the corpus\",\n        \"Direct molecular partners at the spectrin-actin junction not biochemically mapped in the timeline\",\n        \"Causal mutation linking ADD2 to a human Mendelian disease not present\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [],\n    \"complexes\": [\"spectrin-actin membrane skeleton\"],\n    \"partners\": [\"ADD1\", \"ADD3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}